Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2020 | The future landscape of biomarkers for dementia diagnosis

Riona Mc Ardle • 9 Apr 2020
ARUK 2020
Dementia Dementia with Lewy Bodies

Riona Mc Ardle, PhD, Brain and Movement Research Group, Newcastle University, Newcastle upon Tyne, UK, discusses the current landscape of biomarkers for dementia and shares her perspective on the future of biomarkers research, in particular gait. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).

More from Riona Mc Ardle

1:35
Gait impairment and dementia
Riona Mc Ardle • 9 Apr 2020
2:01
Gait as a differential marker of dementia disease subtype
Riona Mc Ardle • 9 Apr 2020
1:36
Gait & dementia: tool to aid clinical decision-making and diagnosis
Riona Mc Ardle • 9 Apr 2020
1:07
Combining gait with other biomarkers for dementia
Riona Mc Ardle • 9 Apr 2020

Related Videos

2:33
Anti-amyloid therapy for Alzheimer's disease: beyond the 18-month mark
Dorota Religa • 22 Mar 2024
0:50
Will long-term anti-amyloid treatment show greater clinical benefit?
Dorota Religa • 22 Mar 2024
1:24
Digital frailty screening in dementia
Dorota Religa • 22 Mar 2024
4:19
Current projects from Alzheimer’s Disease International
Paola Barbarino • 23 Mar 2024
The content of VJDementia is intended for healthcare professionals